Recently, Diao et al. 22 identified ZEB2-AS1 as a putative oncogenic lncRNA and a novel prognostic biomarker in HNSCC, revealed that overexpression of ZEB2-AS1 associates with tumor aggressiveness and unfavorable prognosis. This evidence concerns the gene ZEB2 and head and neck squamous cell carcinoma.